Literature DB >> 16769001

[Controlled, open, parallel-group study of the clinical and microbiological efficacy of piperacillin-tazobactam versus metronidazole + gentamicin in urgent colorectal surgery].

Joana Ferrer1, Constantino Fondevila, Ernest Bombuy, Josep Fuster, Guillermo Alvarez, Ramón Charco, Juan Carlos García-Valdecasas.   

Abstract

INTRODUCTION: Antibiotic treatment is an important element in infection control after urgent abdominal surgery. The aim of this study was to determine the therapeutic efficacy of piperacillin-tazobactam versus a combination of 2 antibiotics (metronidazole and gentamicin) in patients undergoing urgent appendicular and/or colorectal surgery. PATIENTS AND
METHOD: The study period comprised December 1998 to December 2002. A total of 183 patients who required urgent surgery for colon disease and/or severe acute appendicitis were prospectively and randomly included. Patients were randomly distributed in 2 groups. Group A received piperacillin-tazobactam (4/0.5/8 h/i.v.) and group B received metronidazole (500 mg/i.v./8 h) plus gentamicin (5 mg/kg/i.v./24 h). Treatment was started between 30 and 60 minutes prior to surgery and was continued for at least 3 days.
RESULTS: The incidence of wound infection in patients who underwent surgery for colon disease and acute appendicitis was lower when they were treated with piperacillin-tazobactam (P< .05). The incidence of intraperitoneal abscess in the group of patients who underwent surgery for severe acute appendicitis was lower when they were treated with piperacillin-tazobactam. Microbiological analyses revealed that there was a predominance of infection due to Escherichia coli.
CONCLUSIONS: The association of piperacillin-tazobactam was more effective than that of metronidazole and gentamicin in the prevention and treatment of local infection in the treated groups. Therapeutic failure was mainly related to the presence of gram-negative bacteria.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16769001     DOI: 10.1016/s0009-739x(06)70892-2

Source DB:  PubMed          Journal:  Cir Esp        ISSN: 0009-739X            Impact factor:   1.653


  1 in total

1.  Applicability, safety and efficiency of outpatient treatment in uncomplicated diverticulitis.

Authors:  P Moya; A Arroyo; J Pérez-Legaz; P Serrano; F Candela; L Soriano-Irigaray; R Calpena
Journal:  Tech Coloproctol       Date:  2012-06-16       Impact factor: 3.781

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.